• Registered: 2008-12-17
  • Posts: 136

Topic: [NWRN] Newron

Newron wrote:


Outlook

Upcoming milestones include:

  • Top line results for ralfinamide in Neuropathic Low Back Pain, phase IIb/III SERENA study, expected in QII 2010

  • Top line long term results for safinamide as add-on treatment to levodopa in patients with advanced PD (18 months’ extension of study 016)

  • Start of phase I clinical development  with NW-3509

  • Further development of HF0220, with promising prospects for the treatment of neurodegenerative conditions.

more